Decibel Therapeutics (DBTX) Short Interest Ratio & Short Volume

Short interest is the volume of Decibel Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 78,300 shares of DBTX short. 0.63% of Decibel Therapeutics' shares are currently sold short. Learn More on Decibel Therapeutics' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.63% of Decibel Therapeutics' floating shares are currently sold short.

Decibel Therapeutics saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 78,300 shares, a decrease of 64.1% from the previous total of 218,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Decibel Therapeutics currently has issued a total of 25,130,000 shares. Some of Decibel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Decibel Therapeutics currently has a public float of 12,400,000 shares.

0.63% of Decibel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Decibel Therapeutics: Kinnate Biopharma Inc. (2.01%), NGM Biopharmaceuticals, Inc. (4.52%), LianBio (0.36%), So-Young International Inc. (0.07%), Biodesix, Inc. (1.12%), Repare Therapeutics Inc. (2.39%), Citius Pharmaceuticals, Inc. (7.81%), Inotiv, Inc. (4.07%), Karyopharm Therapeutics Inc. (19.94%), Cardiol Therapeutics Inc. (0.53%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

Short selling DBTX is an investing strategy that aims to generate trading profit from Decibel Therapeutics as its price is falling. DBTX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Decibel Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DBTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DBTX, twice per month. The most recent reporting period available is August, 31 2023.